Evidence map›Paper›PMID 36105846›Full record

ReviewInternational journal of general medicine2022

Testosterone Replacement Therapy in the Aged Male: Monitoring Patients' Quality of Life Utilizing Scoring Systems.

Georgios Tsampoukas, Karl H Pang, Athanasios Papatsoris, Mohamad Moussa, Saiful Miah

Open access · goldAbstract readReview
In one paragraph

Review in International journal of general medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Georgios TsampoukasDepartment of Urology, The Great Western Hospital, Swindon, UK.ORCID 0000-0002-2340-7343
Karl H PangInstitute of Andrology, University College London Hospital, London, UK.ORCID 0000-0001-5703-2319
Athanasios PapatsorisU-merge Scientific Office, Athens, Greece.
Mohamad MoussaAl Zahraa Hospital, University Medical Center, Lebanese University, Beirut, Lebanon.ORCID 0000-0001-8571-2768
Saiful MiahDepartment of Urology, Wycombe Hospital, Buckinghamshire NHS Trust, High Wycombe, UK.
Great Western Hospital · GBLebanese University · LBSismanoglio General Hospital · GRUniversity College Hospital · GBWycombe General Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypogonadism has been associated with significant deterioration of well-being. In the aging male, late-onset hypogonadism affects sexual life, mental health, levels of energy, lower urinary tract symptoms and, therefore, quality of life may be found significantly deteriorated. Testosterone replacement or supplementation therapy has been found efficient to reverse the adverse effects of hypogonadism and improve quality of life. Scales and questionnaires assessing the general health, urinary symptoms, sexual health, and cognition can provide a thorough assessment of the clinical syndrome, optimize treatment, assist the follow-up, and facilitate referrals to other specialties depending on the chief complaint. A systematic assessment might combine several tools, but the optimal ones and the exact usage is unknown. In this narrative review, we are flipping through the literature presenting the available tools per domain for the assessment of quality of life in men on testosterone replacement therapy and we discuss the optimal usage.

Indexed as

lower urinary tract symptomsmental healthquality of lifesexual healthtestosterone replacement treatmentwell-being

Identifiers

PMID36105846
PMCPMC9464626
OpenAlexW4295063550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.